Cognitive decline, MCI and early-stage Alzheimer's disease: illustrative image with a REALICA headset
LUCIDA VR · Cognitive decline

Cognitive decline, MCI and early-stage Alzheimer's disease

The clinical picture comes before the choice of tool

Explore the pathwayProject in development · Pathways defined by the professional
01 / Cognitive stimulation

The clinical picture comes before the choice of tool

Mild cognitive impairment, or MCI, describes a condition in which cognitive difficulties exceed those expected for a person's age, while independence in everyday life is largely preserved. It is not the same as a diagnosis of dementia and does not necessarily progress to Alzheimer's disease. Defining the clinical picture requires clinical assessment and monitoring over time. [11]

In early-stage Alzheimer's disease, the care programme also considers the impact of difficulties on everyday life, the support available and the family's needs. A diagnosis does not automatically determine suitability for an immersive experience.

Illustrative environment for cognitive stimulation
The pathway · 02

Assessment for a cognitive pathway

The professional combines medical history, neuropsychological assessment and information about everyday functioning. They also consider understanding of instructions, visual and hearing abilities, motor skills needed for interaction and tolerance of the headset. These elements help distinguish a cognitive difficulty from difficulty accessing the task.

A screening test score does not automatically translate into an exercise level. Performance must be interpreted in the light of the person's profile, context and goals. The programme may require simpler demands, more time or different support, rather than being reduced to a uniform progression in difficulty.

Cognitive stimulation

The planned role of LUCIDA VR

LUCIDA VR offers an environment for guided cognitive activities and observation of the pathway. Its development considers the possibility of selecting relevant tasks, adjusting assistance and reviewing the programme based on feedback from the clinician and the person.

The aim is to offer a tool to be assessed within care, with attention to participation and continuity. Use in different populations, such as people experiencing the effects of stroke or traumatic brain injury, requires specific goals and verification and cannot automatically be equated with use in MCI.

Cognitive stimulation

Benefits to demonstrate and limitations to clarify

More accurate performance in an exercise may reflect task learning and familiarity with the system. Demonstrating a clinical benefit requires independent measures, functional assessments and adequate observation periods. Diagnosis and treatment decisions remain the professional's responsibility.

The next topic

Discover how the programme is defined

Discover how the programme is defined
Continue exploring

In the same area

All topics
A stone arch opens onto a lake among mountains and vegetation

The first step is to talk.

Find out how to get started with REALICA VR.

Contact us
REALICA VR
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.